Eli Lilly Alzheimer’s drug gets FDA panel date after approval delay

An outside panel of advisers to the Food and Drug Administration (FDA) will meet next month to discuss a new Alzheimer’s drug from Eli Lilly, the company said Tuesday. The panel will meet June 10, ... Read More

Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply

Eli Lilly and Novo Nordisk are boosting supply of their weight loss drugs, while Apple Watch’s heart monitoring tech was approved for use in clinical studies. Read More

Weight loss drug Zepbound ‘significantly reduced’ sleep apnea in trials

Eli Lilly’s weight loss drug Zepbound has been shown to “significantly reduce” obstructive sleep ... clinical studies — one in which patients were not on positive airway pressure (PAP ... Read More

Weight Loss Drug Zepbound May Reduce Sleep Apnea, Eli Lilly Says

A late-stage trial of Eli Lilly’s weight loss drug Zepbound showed promising results ... ability to help people lose weight likely helped reduce sleep apnea events, as participants in either ... Read More

US FDA panel to discuss Eli Lilly Alzheimer's drug on June 10

Eli Lilly said on Tuesday a panel of independent U.S. FDA advisers will discuss whether the agency should approve its Alzheimer's disease drug, donanemab, on June 10. Read More

Eli Lilly weight-loss drug found to address sleep apnoea in trial

Eli Lilly’s weight-loss drug tirzepatide significantly reduced ... Wegovy received FDA approval to help reduce heart attack and stroke risk in patients with cardiovascular disease, enabling ... Read More

Sleep apnea reduced in people who took weight-loss drug, Eli Lilly reports

The pharmaceutical manufacturer Eli Lilly announced Wednesday that its obesity drug tirzepatide ... About 60% of patients who use continuous positive airway pressure continue to use it, he ... Read More

Eli Lilly's weight loss drug could help sleep apnea patients

MADISON MILLS: Well, shares of Eli Lilly are rising this morning on news that its weight loss drug helped reduce irregular breathing in patients with sleep apnea in recent late-stage trials. Read More

Studies Show Eli Lilly Weight-Loss Drug Helps With Sleep Apnea

Eli Lilly said a pair of late-stage studies showed that its blockbuster weight-loss tirzepatide significantly reduced the severity of sleep apnea in overweight adults. The company on Wednesday ... Read More

Lilly's weight-loss drug reduces sleep apnea severity in late-stage trials

(Reuters) -Eli Lilly said on Wednesday its weight-loss drug helped reduce episodes of irregular ... obesity and Mounjaro for type 2 diabetes, in patients with obstructive sleep apnea and obesity. Read More

Eli Lilly's weight loss drug Zepbound found to reduce sleep apnea, company says

Eli Lilly’s weight loss drug Zepbound was found to reduce obstructive sleep apnea ... The findings were announced in a news release and have not been published in a medical journal or reviewed ... Read More

Eli Lilly's weight-loss drug succeeds in trials with sleep apnea patients

London: Eli Lilly's weight-loss drug helped cut the frequency of irregular breathing in patients with obstructive sleep apnea by as much as 63 per cent on average across two late-stage trials ... Read More